gemcitabine,brentuximab vedotin
seagen,novartis 
['gemcitabine', 'brentuximab', 'lysa', 'lymphoma', ' vedo', 'lymsm', 'ptcl']
olivier tournilhac: addition of #brentuximab vedotin to gemcitabine in relapsed or refractory #tcell #lymphoma: final analysis of a lysa multicenter, phase ii study. the total trial paper 956 #ash22 #lymsm interesting data! improving very bad pathologies 
Microbiólogo y Médico @UniAndes, Internista @FSFB_salud, Hematólogo de @HematoCAUSA en @HHospitalet, Colaboro @ProyectoIdun #HSCT #Infections #CARTcells #GvHD